This level of confusion, odd deals and hazy atmospheres is more the playground of $2 shelf companies on the Vancouver venture exchange than of a company imagining itself on the NASDAQ.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025